ES508935A0 - "procedimiento para la obtencion de un compuesto polipeptidico tiolado". - Google Patents
"procedimiento para la obtencion de un compuesto polipeptidico tiolado".Info
- Publication number
- ES508935A0 ES508935A0 ES508935A ES508935A ES508935A0 ES 508935 A0 ES508935 A0 ES 508935A0 ES 508935 A ES508935 A ES 508935A ES 508935 A ES508935 A ES 508935A ES 508935 A0 ES508935 A0 ES 508935A0
- Authority
- ES
- Spain
- Prior art keywords
- polypeptic
- thylated
- procedure
- obtaining
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6829—Bacterial toxins, e.g. diphteria toxins or Pseudomonas exotoxin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/825—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8101176A FR2498192A2 (fr) | 1981-01-22 | 1981-01-22 | Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8306714A1 ES8306714A1 (es) | 1983-06-01 |
ES508935A0 true ES508935A0 (es) | 1983-06-01 |
Family
ID=9254407
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES508935A Granted ES508935A0 (es) | 1981-01-22 | 1982-01-21 | "procedimiento para la obtencion de un compuesto polipeptidico tiolado". |
ES519456A Granted ES519456A0 (es) | 1981-01-22 | 1983-02-01 | Procedimiento de union de un compuesto polipeptidico tiolado con una sustancia activa. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES519456A Granted ES519456A0 (es) | 1981-01-22 | 1983-02-01 | Procedimiento de union de un compuesto polipeptidico tiolado con una sustancia activa. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4479940A (es) |
EP (1) | EP0057140B1 (es) |
JP (1) | JPS57176916A (es) |
CA (1) | CA1182811A (es) |
DE (1) | DE3264703D1 (es) |
ES (2) | ES508935A0 (es) |
FR (1) | FR2498192A2 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59116232A (ja) * | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体及びその製造法 |
JPS59116229A (ja) * | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法 |
US4664911A (en) * | 1983-06-21 | 1987-05-12 | Board Of Regents, University Of Texas System | Immunotoxin conjugates employing toxin B chain moieties |
IL69558A (en) * | 1983-08-23 | 1988-06-30 | Yeda Res & Dev | Synthetic cholera vaccine |
US4666884A (en) * | 1984-04-10 | 1987-05-19 | New England Deaconess Hospital | Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls |
FR2567521B1 (fr) * | 1984-07-13 | 1987-01-02 | Sanofi Sa | Nouveaux ionophores actives |
CA1314245C (en) * | 1984-05-23 | 1993-03-09 | Franz Jansen | Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators |
US6022950A (en) * | 1984-06-07 | 2000-02-08 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
US5668255A (en) * | 1984-06-07 | 1997-09-16 | Seragen, Inc. | Hybrid molecules having translocation region and cell-binding region |
FR2575160B1 (fr) * | 1984-12-21 | 1987-03-20 | Sanofi Sa | Composes ionophores carboxyliques monovalents |
US4762710A (en) * | 1986-06-16 | 1988-08-09 | The United States Of America As Represented By The Department Of Health And Human Services | Novel method of preparing toxoid by oxidation and metal ions |
US5084559A (en) * | 1987-03-27 | 1992-01-28 | Repligen Corporation | Protein a domain mutants |
US5601826A (en) * | 1989-06-30 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide which produces protective immunity against tetanus |
GB9020075D0 (en) * | 1990-09-14 | 1990-10-24 | Filler Aaron G | Contrast agents for magnetic resonance imaging of axonal transport |
US5948384A (en) * | 1990-09-14 | 1999-09-07 | Syngenix Limited | Particulate agents |
US6919067B2 (en) * | 1991-09-13 | 2005-07-19 | Syngenix Limited | Compositions comprising a tissue glue and therapeutic agents |
US5716614A (en) * | 1994-08-05 | 1998-02-10 | Molecular/Structural Biotechnologies, Inc. | Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier |
US7923216B2 (en) * | 1997-08-14 | 2011-04-12 | Institut Pasteur | In vivo modulation of neuronal transport |
US7923015B2 (en) * | 1997-08-14 | 2011-04-12 | Institut Pasteur | Methods for direct visualization of active synapses |
US20100081197A1 (en) * | 1997-08-14 | 2010-04-01 | Sylvie Roux | In vivo modulation of neuronal transport |
ES2281135T3 (es) * | 1997-08-14 | 2007-09-16 | Institut Pasteur | Proteinas hibridas de un toxoide tetanico que migran de forma retrograda y transinaptica al snc. |
US6258774B1 (en) * | 1998-03-19 | 2001-07-10 | University Of Medicine And Dentistry Of New Jersey | Carrier for in vivo delivery of a therapeutic agent |
GB0112687D0 (en) * | 2001-05-24 | 2001-07-18 | Microbiological Res Authority | Pharmaceutical use of secreted bacterial effector proteins |
US20070092449A1 (en) * | 2005-04-05 | 2007-04-26 | Rafael Vazquez-Martinez | Methods for direct visualization of active synapses |
ES2332628B1 (es) * | 2007-10-05 | 2011-01-24 | Universidad De Zaragoza | Uso de la secuencia codificante del dominio carboxilo terminal de la cadena pesada de la toxina tetanica como medicamento. |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2938023A (en) * | 1957-04-17 | 1960-05-24 | Hoechst Ag | Manufacture of glutathione containing mercapto groups |
US3171831A (en) * | 1961-02-14 | 1965-03-02 | Schwarz Biores Inc | Thiolation of proteins by reaction with homocysteine thiolactone in the presence of tertiary amine |
DE1617880A1 (de) * | 1966-10-06 | 1971-07-22 | Karl Dr Med Theurer | Verfahren zur Gewinnung von organotropen,bioaktiven Wirkstoffen,insbesondere von Arzneimitteln |
DE2355094C3 (de) * | 1973-11-03 | 1979-05-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines Tetanus-Impfstoffs |
IN140168B (es) * | 1974-10-14 | 1976-09-25 | All India Inst Med | |
JPS5272284A (en) * | 1975-12-12 | 1977-06-16 | Dainippon Pharmaceutical Co | Enzymeeimmunoassay reagent |
JPS5341420A (en) * | 1976-09-29 | 1978-04-14 | Mochida Pharm Co Ltd | Immunochemically measuring methoa of hapten |
US4315031A (en) * | 1977-09-01 | 1982-02-09 | Science Union Et Cie | Thiosubstituted amino acids |
FR2470773B1 (es) * | 1979-11-28 | 1983-01-28 | Pasteur Institut | |
US4284624A (en) * | 1980-05-02 | 1981-08-18 | E. R. Squibb & Sons, Inc. | Mixed disulfides |
-
1981
- 1981-01-22 FR FR8101176A patent/FR2498192A2/fr active Granted
-
1982
- 1982-01-21 CA CA000394587A patent/CA1182811A/en not_active Expired
- 1982-01-21 ES ES508935A patent/ES508935A0/es active Granted
- 1982-01-21 DE DE8282400115T patent/DE3264703D1/de not_active Expired
- 1982-01-21 EP EP82400115A patent/EP0057140B1/fr not_active Expired
- 1982-01-21 US US06/341,335 patent/US4479940A/en not_active Expired - Fee Related
- 1982-01-22 JP JP57007770A patent/JPS57176916A/ja active Pending
-
1983
- 1983-02-01 ES ES519456A patent/ES519456A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ES8306714A1 (es) | 1983-06-01 |
ES8400736A1 (es) | 1983-11-01 |
FR2498192B2 (es) | 1983-09-09 |
JPS57176916A (en) | 1982-10-30 |
FR2498192A2 (fr) | 1982-07-23 |
EP0057140B1 (fr) | 1985-07-17 |
EP0057140A3 (en) | 1982-08-25 |
DE3264703D1 (en) | 1985-08-22 |
ES519456A0 (es) | 1983-11-01 |
CA1182811A (en) | 1985-02-19 |
EP0057140A2 (fr) | 1982-08-04 |
US4479940A (en) | 1984-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES508935A0 (es) | "procedimiento para la obtencion de un compuesto polipeptidico tiolado". | |
ES510449A0 (es) | Un procedimiento para la preparacion de 1,2,4-triazolonas.fenoxial-quilicas. | |
ES515889A0 (es) | Un procedimiento para la preparacion de compuestos. | |
ES512882A0 (es) | Un procedimiento para la preparacion de agentes antifugicos triazolicos. | |
ES508765A0 (es) | Un procedimiento para la obtencion de un compuesto de 4(3h- quinazolinona). | |
ES509911A0 (es) | "un procedimiento para preparar un compuesto de inclusion de ciclodextrina". | |
ES515295A0 (es) | "un procedimiento para la preparacion de imidazoquinazolinas". | |
ES510996A0 (es) | "un procedimiento para preparar compuestos de cefem". | |
ES514652A0 (es) | "un procedimiento para preparar compuestos de cefem". | |
ES510354A0 (es) | Un procedimiento para la preparacion de 2,3-dicloro-5-triclorometilpiridina. | |
ES511941A0 (es) | "un procedimiento para la polimerizacion de un compuesto de eterglicidilico". | |
ES509312A0 (es) | Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona. | |
ES509432A0 (es) | Un procedimiento para la preparacion de arilaminas. | |
ES511874A0 (es) | "un procedimiento para preparar compuestos de mitosano antibioticos". | |
ES516184A0 (es) | "un metodo para la preparacion de 3-fenil-1-indanaminas". | |
ES514572A0 (es) | "un procedimiento para la preparacion de glutation". | |
ES510286A0 (es) | "un procedimiento para la preparacion de nuevas fluoro-prostaciclinas". | |
ES514200A0 (es) | "un procedimiento de fabricacion de telomeros". | |
ES514571A0 (es) | "un procedimiento para la preparacion de glutation". | |
ES510928A0 (es) | "un procedimiento para la preparacion de mercapto-acil-carnitinas". | |
ES515366A0 (es) | Un procedimiento para la preparacion de un compuesto. | |
ES508294A0 (es) | "un procedimiento para preparar n-arilsulfenil-n-diariloxifosfinilmetilglicinatos de alcohilo". | |
ES513832A0 (es) | "un procedimiento para la preparacion de fenetilpiperidinas". | |
ES509526A0 (es) | Un procedimiento para la preparacion de dihigroimidazoles. | |
ES511559A0 (es) | "un procedimiento para la preparacion de (arimeltil) fenil-aminociclohexanos y -ciclohexenos". |